259 related articles for article (PubMed ID: 23690414)
21. The use of methylphenidate to relieve fatigue.
Rojí R; Centeno C
Curr Opin Support Palliat Care; 2017 Dec; 11(4):299-305. PubMed ID: 28885263
[TBL] [Abstract][Full Text] [Related]
22. Methylphenidate in the management of cancer-related fatigue.
Stone PC
J Clin Oncol; 2013 Jul; 31(19):2372-3. PubMed ID: 23690419
[No Abstract] [Full Text] [Related]
23. A phase II study of methylphenidate for depression in advanced cancer.
Homsi J; Nelson KA; Sarhill N; Rybicki L; LeGrand SB; Davis MP; Walsh D
Am J Hosp Palliat Care; 2001; 18(6):403-7. PubMed ID: 11712722
[TBL] [Abstract][Full Text] [Related]
24. Double-blind, randomized trial of dexmethylphenidate hydrochloride for the treatment of sarcoidosis-associated fatigue.
Lower EE; Harman S; Baughman RP
Chest; 2008 May; 133(5):1189-95. PubMed ID: 18263672
[TBL] [Abstract][Full Text] [Related]
25. 5-EPIFAT trial protocol: a multi-center, randomized, placebo-controlled trial of the efficacy of pharmacotherapy for fatigue using methylphenidate, bupropion, ginseng, and amantadine in advanced cancer patients on active treatment.
Miladinia M; Jahangiri M; White SJ; Karimpourian H; Inno A; Chan SW; Ganji R; Maniati M; Zarea K; Ghalamkari M; Farahat A; Fagerström C
Trials; 2024 Apr; 25(1):230. PubMed ID: 38570861
[TBL] [Abstract][Full Text] [Related]
26. Open-Label Placebo for the Treatment of Cancer-Related Fatigue in Patients with Advanced Cancer: A Randomized Controlled Trial.
Yennurajalingam S; Azhar A; Lu Z; Rodriguez AJ; Arechiga AB; Guerra-Sanchez M; Stanton P; Andersen CR; Urbauer DL; Bruera E
Oncologist; 2022 Dec; 27(12):1081-1089. PubMed ID: 36106759
[TBL] [Abstract][Full Text] [Related]
27. Methylphenidate improves fatigue scores in Parkinson disease: a randomized controlled trial.
Mendonça DA; Menezes K; Jog MS
Mov Disord; 2007 Oct; 22(14):2070-6. PubMed ID: 17674415
[TBL] [Abstract][Full Text] [Related]
28. A randomized, double-blind, 2-period, placebo-controlled crossover trial of a sustained-release methylphenidate in the treatment of fatigue in cancer patients.
Escalante CP; Meyers C; Reuben JM; Wang X; Qiao W; Manzullo E; Alvarez RH; Morrow PK; Gonzalez-Angulo AM; Wang XS; Mendoza T; Liu W; Holmes H; Hwang J; Pisters K; Overman M; Cleeland C
Cancer J; 2014; 20(1):8-14. PubMed ID: 24445757
[TBL] [Abstract][Full Text] [Related]
29. A systematic review and meta-analysis of the pharmacological treatment of cancer-related fatigue.
Minton O; Richardson A; Sharpe M; Hotopf M; Stone P
J Natl Cancer Inst; 2008 Aug; 100(16):1155-66. PubMed ID: 18695134
[TBL] [Abstract][Full Text] [Related]
30. Melatonin Supplementation for Cancer-Related Fatigue in Patients With Early Stage Breast Cancer Receiving Radiotherapy: A Double-Blind Placebo-Controlled Trial.
Mukhopadhyay ND; Khorasanchi A; Pandey S; Nemani S; Parker G; Deng X; Arthur DW; Urdaneta A; Del Fabbro E
Oncologist; 2024 Feb; 29(2):e206-e212. PubMed ID: 37699115
[TBL] [Abstract][Full Text] [Related]
31. Methylphenidate Versus Placebo for Treating Fatigue in Patients With Advanced Cancer: Randomized, Double-Blind, Multicenter, Placebo-Controlled Trial.
Stone PC; Minton O; Richardson A; Buckle P; Enayat ZE; Marston L; Freemantle N
J Clin Oncol; 2024 May; ():JCO2302639. PubMed ID: 38757263
[TBL] [Abstract][Full Text] [Related]
32. Combination Therapy of Physical Activity and Dexamethasone for Cancer-Related Fatigue: A Phase II Randomized Double-Blind Controlled Trial.
Yennurajalingam S; Valero V; Lu Z; Liu DD; Busaidy NL; Reuben JM; Diaz Fleming C; Williams JL; Hess KR; Basen-Engquist K; Bruera E
J Natl Compr Canc Netw; 2021 Dec; 20(3):235-243. PubMed ID: 34965510
[TBL] [Abstract][Full Text] [Related]
33. Multicentre, double-blind, randomised placebo-controlled clinical trial on the efficacy of methylphenidate on depressive symptoms in advanced cancer patients.
Centeno C; Sanz A; Cuervo MA; Ramos D; Hernansanz S; Gonzalez J; Almaraz MJ; Lama M; Vara F; Nabal M; Pascual A
BMJ Support Palliat Care; 2012 Dec; 2(4):328-33. PubMed ID: 24654216
[TBL] [Abstract][Full Text] [Related]
34. Cancer-related fatigue among patients with advanced cancer receiving immune-checkpoint inhibitors: a prospective study.
Yennurajalingam S; Thomas L; Stanton PA; Lu Z; de Moraes AR; Bruera E
Support Care Cancer; 2024 Jun; 32(7):459. PubMed ID: 38918253
[TBL] [Abstract][Full Text] [Related]
35. Phase II, randomised, double-blind, placebo-controlled trial of methylphenidate for reduction of fatigue levels in patients with prostate cancer receiving LHRH-agonist therapy.
Richard PO; Fleshner NE; Bhatt JR; Hersey KM; Chahin R; Alibhai SM
BJU Int; 2015 Nov; 116(5):744-52. PubMed ID: 24684534
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of corticosteroids for cancer-related fatigue: A pilot randomized placebo-controlled trial of advanced cancer patients.
Eguchi K; Honda M; Kataoka T; Mukouyama T; Tsuneto S; Sakamoto J; Oba K; Saji S
Palliat Support Care; 2015 Oct; 13(5):1301-8. PubMed ID: 25370595
[TBL] [Abstract][Full Text] [Related]
37. Pilot study to determine the optimal dose of methylphenidate for an n-of-1 trial for fatigue in patients with cancer.
Hardy JR; Carmont SA; O'Shea A; Vora R; Schluter P; Nikles CJ; Mitchell GK
J Palliat Med; 2010 Oct; 13(10):1193-7. PubMed ID: 20831434
[TBL] [Abstract][Full Text] [Related]
38. A phase II study of methylphenidate for the treatment of fatigue.
Hanna A; Sledge G; Mayer ML; Hanna N; Einhorn L; Monahan P; Daggy J; Bhatia S
Support Care Cancer; 2006 Mar; 14(3):210-5. PubMed ID: 16096772
[TBL] [Abstract][Full Text] [Related]
39. Feasibility study of a randomised controlled trial to investigate the treatment of sarcoidosis-associated fatigue with methylphenidate (FaST-MP): a study protocol.
Atkins C; Fordham R; Clark AB; Stockl A; Jones AP; Wilson AM
BMJ Open; 2017 Dec; 7(12):e018532. PubMed ID: 29208618
[TBL] [Abstract][Full Text] [Related]
40. The Effect of Methylphenidate on Fatigue in Advanced Cancer: An Aggregated N-of-1 Trial.
Mitchell GK; Hardy JR; Nikles CJ; Carmont SA; Senior HE; Schluter PJ; Good P; Currow DC
J Pain Symptom Manage; 2015 Sep; 50(3):289-96. PubMed ID: 25896104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
